No connection

Search Results

APPN

NEUTRAL
$25.59 Live
Appian Corporation · NASDAQ
Target $31.0 (+21.1%)
$21.77 52W Range $46.06

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Mar 14, 2026
Market cap
$1.89B
P/E
1279.5
ROE
N/A
Profit margin
0.2%
Debt/Equity
N/A
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
78%
Appian Corporation exhibits strong deterministic health with a Piotroski F-Score of 7/9, indicating solid operational efficiency and financial stability despite lacking an Altman Z-Score for bankruptcy risk assessment. The company demonstrates robust revenue growth at 21.7% YoY and a high gross margin of 72.54%, underpinned by consistent earnings surprises averaging 228% over the last four quarters. However, the stock trades at an extremely high forward P/E of 21.99 and a negative Price/Book of -40.30, reflecting deep market skepticism about current profitability and asset value. While insider sentiment is bearish due to a recent sale, analyst target prices suggest upside potential, though consensus remains weak. The intrinsic value estimate of $0.14 is vastly below current price, signaling a significant premium driven by growth expectations.

Key Strengths

Piotroski F-Score of 7/9 indicates strong financial health and operational efficiency
Consistently beats earnings estimates with average surprise of 228% over last 4 quarters
High gross margin of 72.54% reflects strong pricing power and cost control
21.7% YoY revenue growth demonstrates solid top-line expansion
Positive Q/Q EPS growth of +157.7% signals improving profitability trajectory

Key Risks

Forward P/E of 21.99 is elevated relative to sector average of 75.92, suggesting overvaluation
Negative Price/Book (-40.30) implies market values assets at a significant discount or negative equity
No dividend and zero payout ratio indicate no return to shareholders
Insider selling activity (1 transaction, $0.26M) signals bearish sentiment among insiders
Lack of Altman Z-Score and missing debt/equity, cash, and FCF data limits financial health assessment
AI Fair Value Estimate
Based on comprehensive analysis
$0.14
-99.5% below current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
51
Moderate
Value
45
Future
78
Past
68
Health
65
Dividend
0
AI Verdict
neutral
Key drivers: Strong Piotroski F-Score and earnings surprise history, High revenue growth and gross margin, Overvalued forward P/E and negative Price/Book, Lack of financial health metrics (Altman Z, Debt/Equity), Bearish insider activity and no dividend
Confidence
75%
Value
45/100

Ref P/E, PEG, Graham Number

Positives
  • Forward P/E of 21.99 is below sector average of 75.92
  • Gross margin of 72.54% is industry-leading
Watchpoints
  • Price/Book of -40.30 indicates negative equity or asset overvaluation
  • Intrinsic value estimate of $0.14 is far below current price of $25.59
  • No Graham Number available, limiting defensive valuation
Future
78/100

Ref Growth rates

Positives
  • 21.7% YoY revenue growth is strong for software sector
  • Earnings growth of +157.7% YoY indicates accelerating profitability
  • Recent quarters show consistent beat rates (3/4 in last 4)
Watchpoints
  • No PEG ratio available, limiting growth-adjusted valuation
  • Forward P/E remains high despite growth
Past
68/100

Ref Historical trends

Positives
  • Piotroski F-Score of 7/9 reflects strong historical financial performance
  • Consistent earnings beat history with average surprise of 228%
  • Improving EPS trend from losses to positive profitability
Watchpoints
  • Historical earnings were deeply negative (e.g., -$0.46 in 2022)
  • Negative operating margin of 1.67% suggests inefficiencies
Health
65/100

Ref Altman Z-Score, Piotroski F-Score

Positives
  • Piotroski F-Score of 7/9 indicates strong financial health
  • Current ratio of 1.15 and quick ratio of 1.00 suggest adequate liquidity
Watchpoints
  • No Altman Z-Score available, preventing distress risk assessment
  • Missing Debt/Equity, Total Debt, and Total Cash data
  • Negative Price/Book raises concerns about balance sheet strength
Dividend
0/100

Ref Yield, Payout

Positives
No standout positives identified.
Watchpoints
  • No dividend yield or payout ratio
  • Dividend Strength score of 0/100 indicates no return to shareholders

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$25.59
Analyst Target
$31.0
Upside/Downside
+21.1%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for APPN and closest competitors.

Updated 2026-03-13
APP
Appian Corporation
Primary
5Y
-85.0%
3Y
-37.5%
1Y
-11.8%
6M
-16.9%
1M
+9.3%
1W
-3.9%
FOR
Formula Systems (1985) Ltd.
Peer
5Y
+46.6%
3Y
+103.2%
1Y
+45.4%
6M
-16.8%
1M
-2.9%
1W
-0.3%
AGY
Agilysys, Inc.
Peer
5Y
+17.1%
3Y
-15.7%
1Y
-4.1%
6M
-35.3%
1M
-20.0%
1W
-11.6%
MXL
MaxLinear, Inc.
Peer
5Y
-42.6%
3Y
-31.6%
1Y
+117.8%
6M
+27.7%
1M
+24.5%
1W
+17.1%
PAY
Payoneer Global Inc.
Peer
5Y
-49.3%
3Y
-8.8%
1Y
-19.3%
6M
-9.6%
1M
+9.1%
1W
+13.4%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
1279.5
Forward P/E
21.99
PEG Ratio
N/A
P/B Ratio
-40.3
P/S Ratio
2.6
EV/Revenue
2.76
EV/EBITDA
93.26
Market Cap
$1.89B

Profitability

Profit margins and return metrics

Profit Margin 0.17%
Operating Margin 1.67%
Gross Margin 72.54%
ROE N/A
ROA 1.12%

Growth

Revenue and earnings growth rates

Revenue Growth +21.7%
Earnings Growth N/A
Q/Q Revenue Growth N/A
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
N/A
Current Ratio
1.15
Good
Quick Ratio
1.0
Good
Cash/Share
$2.53

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue
$0.2B
Gross Margin
64.8%
Op. Margin
-0.3%
Net Margin
-2.5%
Total Assets
$0.7B
Liabilities
$0.7B
Equity
$-0.0B
Debt/Equity
-15.71x
Operating CF
$0.0B
CapEx
$-0.0B
Free Cash Flow
$0.0B
FCF Yield
24%

Quarterly Earnings History

EPS performance vs analyst estimates

2026-05-07
$N/A
2026-02-19
$0.15
+91.5% surprise
2025-11-06
$0.32
+490.0% surprise
2025-08-07
$N/A
+103.0% surprise

Technology Sector Comparison

Comparing APPN against 597 companies in the Technology sector (46 bullish, 214 neutral, 337 bearish)
P/E Ratio
1279.5
This Stock
vs
80.99
Sector Avg
+1479.8% (Expensive)
Profit Margin
0.17%
This Stock
vs
-11.8%
Sector Avg
-101.4% (Weaker)
Revenue Growth
21.7%
This Stock
vs
4143.28%
Sector Avg
-99.5% (Slower)
Current Ratio
1.15
This Stock
vs
3.7
Sector Avg
-68.9% (Weaker)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

DORSEY MARK
Officer
Stock Award
2026-03-05
3,750 shares
TANJGA SRDJAN
Chief Financial Officer
Stock Award
2026-03-05
16,277 shares
LYNCH MARK STEVEN
Director
Sell
2026-03-03
9,530 shares · $257,310
KRAMER ROBERT CHARLES
Officer and Director
Stock Award
2026-03-03
3,770 shares
LYNCH MARK STEVEN
Director
Option Exercise
2026-03-03
9,530 shares · $90,408
ZAMUDIO-RAMIREZ PAVEL
Officer
Stock Award
2026-03-03
2,259 shares
CALKINS MATTHEW W
Chief Executive Officer
Stock Award
2026-03-03
64,375 shares
KILBERG BOBBIE G
Director
Stock Award
2026-02-18
21,600 shares
LINK DAVID FORREST
Director
Stock Award
2026-02-04
771 shares
MCCARTHY WILLIAM D
Director
Stock Award
2025-12-31
882 shares
BIDDLE ALBERT G.W. III
Director
Stock Award
2025-12-31
235 shares
KILBERG BOBBIE G
Director
Stock Award
2025-12-31
882 shares
LYNCH MARK STEVEN
Director
Stock Award
2025-12-31
882 shares
EDWARDS SHIRLEY ANN
Director
Stock Award
2025-12-31
882 shares
HARTMAN CARL JOSEPH II
Director
Stock Award
2025-12-31
882 shares
Insider transactions can signal confidence or concerns about company prospects

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
NONE
5 analysts
Citigroup
2026-02-20
Maintains
Buy Buy
TD Cowen
2026-02-20
Maintains
Hold Hold
Barclays
2026-02-20
Maintains
Underweight Underweight
Barclays
2026-01-12
Maintains
Underweight Underweight
Morgan Stanley
2026-01-12
up
Equal-Weight Overweight
Morgan Stanley
2025-11-11
Maintains
Equal-Weight Equal-Weight
Barclays
2025-11-07
Maintains
Underweight Underweight

Past News Coverage

Recent headlines mentioning APPN from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile